Healthcare provider profile · identity verified

Christopher Faison, M.D.

Family Practice · WHITE SALMON, WA · NPI 1033434964

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	158	45
Losartan Potassium	Losartan Potassium	123	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	122	18
Amlodipine Besylate	Amlodipine Besylate	119	35
Atorvastatin Calcium	Atorvastatin Calcium	110	36
Levothyroxine Sodium	Levothyroxine Sodium	107	28
Omeprazole	Omeprazole	104	25
Hydrochlorothiazide	Hydrochlorothiazide	87	24
Gabapentin	Gabapentin	76	25
Metformin Hcl	Metformin Hcl	76	17
Simvastatin	Simvastatin	74	16
Furosemide	Furosemide	72	19
Tramadol Hcl	Tramadol Hcl	72	15
Sertraline Hcl	Sertraline Hcl	65	13
Metformin Hcl Er	Metformin Hcl	58	18
Metoprolol Succinate	Metoprolol Succinate	56	15
Tamsulosin Hcl	Tamsulosin Hcl	54	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	suppressed
Potassium Chloride	Potassium Chloride	47	11
Trazodone Hcl	Trazodone Hcl	47	13
Triamcinolone Acetonide	Triamcinolone Acetonide	44	16
Lorazepam	Lorazepam	42	14
Oxycodone Hcl	Oxycodone Hcl	41	suppressed
Bupropion Xl	Bupropion Hcl	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	35	11
Lovastatin	Lovastatin	34	suppressed
Ozempic	Semaglutide	33	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Eliquis	Apixaban	31	suppressed
Finasteride	Finasteride	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Prednisone	Prednisone	27	14
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Carvedilol	Carvedilol	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	suppressed
Risperidone	Risperidone	26	suppressed
Atenolol	Atenolol	25	suppressed
Concerta	Methylphenidate Hcl	25	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Torsemide	Torsemide	23	suppressed
Trulicity	Dulaglutide	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Alprazolam	Alprazolam	21	suppressed
Diazepam	Diazepam	21	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Baclofen	Baclofen	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Invega Sustenna	Paliperidone Palmitate	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	16	suppressed
Armour Thyroid	Thyroid,pork	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Indomethacin	Indomethacin	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error